iE
Non vérifié

iECURE, Inc.

Ce que nous écrivons

BiotechnologieIndustrieMédecine - DiversSantéScience
27/08/2026
Événements
Industrie
Santé
Biotechnologie
Médecine - Divers
Science
Industrie pharmaceutique
iECURE Presents Updated Clinical Data from OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM 2026
1.00
20/08/2026
Événements
Industrie
Biotechnologie
Industrie pharmaceutique
Santé
Services Sociaux
Vitrines/Shopping
Médecine - Divers
iECURE to Present Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM Annual Symposium
1.00
13/05/2026
Événements
Expos
Industrie
Santé
Biotechnologie
Médecine - Divers
Science
Industrie pharmaceutique
iECURE Presents Preliminary Clinical Data from Ongoing Clinical Trial of ECUR-506 in Ornithine Transcarbamylase Deficiency at the ASGCT Annual Meeting
1.00
28/04/2026
Téléphonie et Divers
Expos
Industrie
Science
Enfance
Services Sociaux
Biotechnologie
Médecine - Divers
Santé
Vitrines/Shopping
iECURE to Present Preliminary Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at the ASGCT and SIMD Annual Meetings
1.00
18/03/2026
Biotechnologie
Hygiène alimentaire
Santé
Santé Publique
Industrie pharmaceutique
Science
VIH, SIDA et maladies auto-immunes
Médecine - Divers
Industrie
iECURE Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of ECUR-506 Ahead of Planned BLA Submission
1.00
06/05/2025
Événements
Santé
Vitrines/Shopping
Biotechnologie
Services Sociaux
Médecine - Divers
Science
iECURE to Present Initial OTC-HOPE Clinical Data of ECUR-506 in Ornithine Transcarbamylase Deficiency at Upcoming Medical Meetings
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0